| Bioactivity | CBP501 Affinity Peptide is a Chk kinase inhibitor that can abrogate G2 arrest induced by DNA-damaging agents. CBP501 Affinity Peptide can be used in cancer research[1]. |
| Name | CBP501 Affinity Peptide |
| CAS | 1351804-17-5 |
| Sequence | Asn-Ser-Asp-Cys-Ile-Ile-Ser-Arg-Lys-Ile-Glu-Gln-Lys-Glu |
| Shortening | NSDCIISRKIEQKE |
| Formula | C68H119N21O25S |
| Molar Mass | 1662.86 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Matsumoto Y, et al. Screening of a library of T7 phage-displayed peptides identifies alphaC helix in 14-3-3 protein as a CBP501-binding site. Bioorg Med Chem. 2011 Dec 1;19(23):7049-56. |
CBP501 Affinity Peptide
CAS: 1351804-17-5 F: C68H119N21O25S W: 1662.86
CBP501 Affinity Peptide is a Chk kinase inhibitor that can abrogate G2 arrest induced by DNA-damaging agents. CBP501 Aff
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.